Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 565 to 576 of 576 entries
Sorted by: Best Match Show Resources per page
Diffusive Ki67 and vimentin are associated with worse recurrence-free survival of upper tract urothelial carcinoma: A retrospective cohort study from bench to bedside.

Urologic oncology

Yang CH, Weng WC, Ou YC, Lin YS, Huang LH, Lu CH, Tsao TY, Hsu CY, Tung MC.
PMID: 34750051
Urol Oncol. 2021 Nov 05; doi: 10.1016/j.urolonc.2021.09.018. Epub 2021 Nov 05.

OBJECTIVES: This study aimed to determine the prognostic values of Ki67 and vimentin in upper tract urothelial carcinoma (UTUC) after extirpative surgery.METHODS AND MATERIALS: Between 2014 and 2019, patients diagnosed with UTUC and receiving radical nephroureterectomy were included retrospectively....

Cite
Yang CH, Weng WC, Ou YC, et al. Diffusive Ki67 and vimentin are associated with worse recurrence-free survival of upper tract urothelial carcinoma: A retrospective cohort study from bench to bedside. Urol Oncol. 2021;doi: 10.1016/j.urolonc.2021.09.018.
Yang, C. H., Weng, W. C., Ou, Y. C., Lin, Y. S., Huang, L. H., Lu, C. H., Tsao, T. Y., Hsu, C. Y., & Tung, M. C. (2021). Diffusive Ki67 and vimentin are associated with worse recurrence-free survival of upper tract urothelial carcinoma: A retrospective cohort study from bench to bedside. Urologic oncology, . https://doi.org/10.1016/j.urolonc.2021.09.018
Yang, Che Hsueh, et al. "Diffusive Ki67 and vimentin are associated with worse recurrence-free survival of upper tract urothelial carcinoma: A retrospective cohort study from bench to bedside." Urologic oncology vol. (2021). doi: https://doi.org/10.1016/j.urolonc.2021.09.018
Yang CH, Weng WC, Ou YC, Lin YS, Huang LH, Lu CH, Tsao TY, Hsu CY, Tung MC. Diffusive Ki67 and vimentin are associated with worse recurrence-free survival of upper tract urothelial carcinoma: A retrospective cohort study from bench to bedside. Urol Oncol. 2021 Nov 05; doi: 10.1016/j.urolonc.2021.09.018. Epub 2021 Nov 05. PMID: 34750051.
Copy Download .nbib Format: NLM
Academic Publication of Anesthesiology From a Bibliographic Perspective From 1999 to 2018: Comparative Analysis Using Subject-Field Dataset and Department Dataset.

Frontiers in medicine

Chen SY, Wei LF, Huang MH, Ho CM.
PMID: 34660616
Front Med (Lausanne). 2021 Sep 29;8:658833. doi: 10.3389/fmed.2021.658833. eCollection 2021.

No abstract available.

Cite
Chen SY, Wei LF, Huang MH, et al. Academic Publication of Anesthesiology From a Bibliographic Perspective From 1999 to 2018: Comparative Analysis Using Subject-Field Dataset and Department Dataset. Front Med (Lausanne). 2021;8:658833doi: 10.3389/fmed.2021.658833.
Chen, S. Y., Wei, L. F., Huang, M. H., & Ho, C. M. (2021). Academic Publication of Anesthesiology From a Bibliographic Perspective From 1999 to 2018: Comparative Analysis Using Subject-Field Dataset and Department Dataset. Frontiers in medicine, 8658833. https://doi.org/10.3389/fmed.2021.658833
Chen, Sy-Yuan, et al. "Academic Publication of Anesthesiology From a Bibliographic Perspective From 1999 to 2018: Comparative Analysis Using Subject-Field Dataset and Department Dataset." Frontiers in medicine vol. 8 (2021): 658833. doi: https://doi.org/10.3389/fmed.2021.658833
Chen SY, Wei LF, Huang MH, Ho CM. Academic Publication of Anesthesiology From a Bibliographic Perspective From 1999 to 2018: Comparative Analysis Using Subject-Field Dataset and Department Dataset. Front Med (Lausanne). 2021 Sep 29;8:658833. doi: 10.3389/fmed.2021.658833. eCollection 2021. PMID: 34660616; PMCID: PMC8511392.
Copy Download .nbib Format: NLM
CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice.

Molecular therapy. Methods & clinical development

Stone D, Long KR, Loprieno MA, De Silva Feelixge HS, Kenkel EJ, Liley RM, Rapp S, Roychoudhury P, Nguyen T, Stensland L, Colón-Thillet R, Klouser LM, Weber ND, Le C, Wagoner J, Goecker EA, Li AZ, Eichholz K, Corey L, Tyrrell DL, Greninger AL, Huang ML, Polyak SJ, Aubert M, Sagartz JE, Jerome KR.
PMID: 33473359
Mol Ther Methods Clin Dev. 2020 Nov 26;20:258-275. doi: 10.1016/j.omtm.2020.11.014. eCollection 2021 Mar 12.

Chronic hepatitis B virus (HBV) infection is a major public health problem. New treatment approaches are needed because current treatments do not target covalently closed circular DNA (cccDNA), the template for HBV replication, and rarely clear the virus. We...

Cite
Stone D, Long KR, Loprieno MA, et al. CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice. Mol Ther Methods Clin Dev. 2020;20:258-275doi: 10.1016/j.omtm.2020.11.014.
Stone, D., Long, K. R., Loprieno, M. A., De Silva Feelixge, H. S., Kenkel, E. J., Liley, R. M., Rapp, S., Roychoudhury, P., Nguyen, T., Stensland, L., Colón-Thillet, R., Klouser, L. M., Weber, N. D., Le, C., Wagoner, J., Goecker, E. A., Li, A. Z., Eichholz, K., Corey, L., Tyrrell, D. L., Greninger, A. L., Huang, M. L., Polyak, S. J., Aubert, M., Sagartz, J. E., & Jerome, K. R. (2021). CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice. Molecular therapy. Methods & clinical development, 20258-275. https://doi.org/10.1016/j.omtm.2020.11.014
Stone, Daniel, et al. "CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice." Molecular therapy. Methods & clinical development vol. 20 (2021): 258-275. doi: https://doi.org/10.1016/j.omtm.2020.11.014
Stone D, Long KR, Loprieno MA, De Silva Feelixge HS, Kenkel EJ, Liley RM, Rapp S, Roychoudhury P, Nguyen T, Stensland L, Colón-Thillet R, Klouser LM, Weber ND, Le C, Wagoner J, Goecker EA, Li AZ, Eichholz K, Corey L, Tyrrell DL, Greninger AL, Huang ML, Polyak SJ, Aubert M, Sagartz JE, Jerome KR. CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice. Mol Ther Methods Clin Dev. 2020 Nov 26;20:258-275. doi: 10.1016/j.omtm.2020.11.014. eCollection 2021 Mar 12. PMID: 33473359; PMCID: PMC7803634.
Copy Download .nbib Format: NLM
microRNA-378b Regulates Ethanol-Induced Hepatic Steatosis by Targeting CaMKK2 to Mediate Lipid Metabolism.

Bioengineered

Wang YZ, Lu J, Li YY, Zhong YJ, Yang CF, Zhang Y, Huang LH, Huang SM, Li QR, Wu D, Song MW, Shi L, Li L, Li YW.
PMID: 34898362
Bioengineered. 2021 Dec 13; doi: 10.1080/21655979.2021.2003677. Epub 2021 Dec 13.

Alcoholic liver disease (ALD) has seriously harmed the health of people worldwide, but its underlying mechanisms remain unclear. This study aims to clarify the biological function of microRNA-378b (miR-378b) in ethanol (EtOH)-induced hepatic lipid accumulation. Here, we report miR-378b...

Cite
Wang YZ, Lu J, Li YY, et al. microRNA-378b Regulates Ethanol-Induced Hepatic Steatosis by Targeting CaMKK2 to Mediate Lipid Metabolism. Bioengineered. 2021;doi: 10.1080/21655979.2021.2003677.
Wang, Y. Z., Lu, J., Li, Y. Y., Zhong, Y. J., Yang, C. F., Zhang, Y., Huang, L. H., Huang, S. M., Li, Q. R., Wu, D., Song, M. W., Shi, L., Li, L., & Li, Y. W. (2021). microRNA-378b Regulates Ethanol-Induced Hepatic Steatosis by Targeting CaMKK2 to Mediate Lipid Metabolism. Bioengineered, . https://doi.org/10.1080/21655979.2021.2003677
Wang, Ying-Zhao, et al. "microRNA-378b Regulates Ethanol-Induced Hepatic Steatosis by Targeting CaMKK2 to Mediate Lipid Metabolism." Bioengineered vol. (2021). doi: https://doi.org/10.1080/21655979.2021.2003677
Wang YZ, Lu J, Li YY, Zhong YJ, Yang CF, Zhang Y, Huang LH, Huang SM, Li QR, Wu D, Song MW, Shi L, Li L, Li YW. microRNA-378b Regulates Ethanol-Induced Hepatic Steatosis by Targeting CaMKK2 to Mediate Lipid Metabolism. Bioengineered. 2021 Dec 13; doi: 10.1080/21655979.2021.2003677. Epub 2021 Dec 13. PMID: 34898362.
Copy Download .nbib Format: NLM
Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity.

JAMA network open

Stankiewicz Karita HC, Dong TQ, Johnston C, Neuzil KM, Paasche-Orlow MK, Kissinger PJ, Bershteyn A, Thorpe LE, Deming M, Kottkamp A, Laufer M, Landovitz RJ, Luk A, Hoffman R, Roychoudhury P, Magaret CA, Greninger AL, Huang ML, Jerome KR, Wener M, Celum C, Chu HY, Baeten JM, Wald A, Barnabas RV, Brown ER.
PMID: 35006245
JAMA Netw Open. 2022 Jan 04;5(1):e2142796. doi: 10.1001/jamanetworkopen.2021.42796.

IMPORTANCE: The SARS-CoV-2 viral trajectory has not been well characterized in incident infections. These data are needed to inform natural history, prevention practices, and therapeutic development.OBJECTIVE: To characterize early SARS-CoV-2 viral RNA load (hereafter referred to as viral load)...

Cite
Stankiewicz Karita HC, Dong TQ, Johnston C, et al. Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity. JAMA Netw Open. 2022;5(1):e2142796doi: 10.1001/jamanetworkopen.2021.42796.
Stankiewicz Karita, H. C., Dong, T. Q., Johnston, C., Neuzil, K. M., Paasche-Orlow, M. K., Kissinger, P. J., Bershteyn, A., Thorpe, L. E., Deming, M., Kottkamp, A., Laufer, M., Landovitz, R. J., Luk, A., Hoffman, R., Roychoudhury, P., Magaret, C. A., Greninger, A. L., Huang, M. L., Jerome, K. R., Wener, M., Celum, C., Chu, H. Y., Baeten, J. M., Wald, A., Barnabas, R. V., & Brown, E. R. (2022). Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity. JAMA network open, 5(1), e2142796. https://doi.org/10.1001/jamanetworkopen.2021.42796
Stankiewicz Karita, Helen C, et al. "Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity." JAMA network open vol. 5,1 (2022): e2142796. doi: https://doi.org/10.1001/jamanetworkopen.2021.42796
Stankiewicz Karita HC, Dong TQ, Johnston C, Neuzil KM, Paasche-Orlow MK, Kissinger PJ, Bershteyn A, Thorpe LE, Deming M, Kottkamp A, Laufer M, Landovitz RJ, Luk A, Hoffman R, Roychoudhury P, Magaret CA, Greninger AL, Huang ML, Jerome KR, Wener M, Celum C, Chu HY, Baeten JM, Wald A, Barnabas RV, Brown ER. Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity. JAMA Netw Open. 2022 Jan 04;5(1):e2142796. doi: 10.1001/jamanetworkopen.2021.42796. PMID: 35006245.
Copy Download .nbib Format: NLM
Implementing technology enhanced real-time action observation therapy in persons with chronic stroke: A pilot study.

Physiotherapy theory and practice

Roberts M, Lietz NH, Portelli NA, Huang MH.
PMID: 34503381
Physiother Theory Pract. 2021 Sep 09;1-12. doi: 10.1080/09593985.2021.1978120. Epub 2021 Sep 09.

This pilot study examined a novel technology-enhanced real-time action observation therapy (TERTAOT) of symmetrical bilateral movements in survivors of chronic stroke regardless of their ability to move their paretic limb(s). The TERTAOT used a Kinect XBox One to project...

Cite
Roberts M, Lietz NH, Portelli NA, et al. Implementing technology enhanced real-time action observation therapy in persons with chronic stroke: A pilot study. Physiother Theory Pract. 2021;1-12doi: 10.1080/09593985.2021.1978120.
Roberts, M., Lietz, N. H., Portelli, N. A., & Huang, M. H. (2021). Implementing technology enhanced real-time action observation therapy in persons with chronic stroke: A pilot study. Physiotherapy theory and practice, 1-12. https://doi.org/10.1080/09593985.2021.1978120
Roberts, Mary, et al. "Implementing technology enhanced real-time action observation therapy in persons with chronic stroke: A pilot study." Physiotherapy theory and practice vol. (2021): 1-12. doi: https://doi.org/10.1080/09593985.2021.1978120
Roberts M, Lietz NH, Portelli NA, Huang MH. Implementing technology enhanced real-time action observation therapy in persons with chronic stroke: A pilot study. Physiother Theory Pract. 2021 Sep 09;1-12. doi: 10.1080/09593985.2021.1978120. Epub 2021 Sep 09. PMID: 34503381.
Copy Download .nbib Format: NLM
Genetic diversity and main functional composition of Lingzhi strains from main producing areas in China.

AMB Express

Liu YC, Tang XC, Hu HP, Chen DL, Xie YZ, Liang XW, Li XM, Xiao C, Huang LH, Wu QP.
PMID: 34417676
AMB Express. 2021 Aug 21;11(1):119. doi: 10.1186/s13568-021-01280-y.

In this study, we used genotyping by sequencing (GBS) to examine the genetic diversity of 22 strains of Lingzhi and the quality differences in 15 fruit bodies of Lingzhi from different Chinese regions. The phylogenetic trees of 22 strains...

Cite
Liu YC, Tang XC, Hu HP, et al. Genetic diversity and main functional composition of Lingzhi strains from main producing areas in China. AMB Express. 2021;11(1):119doi: 10.1186/s13568-021-01280-y.
Liu, Y. C., Tang, X. C., Hu, H. P., Chen, D. L., Xie, Y. Z., Liang, X. W., Li, X. M., Xiao, C., Huang, L. H., & Wu, Q. P. (2021). Genetic diversity and main functional composition of Lingzhi strains from main producing areas in China. AMB Express, 11(1), 119. https://doi.org/10.1186/s13568-021-01280-y
Liu, Yuan-Chao, et al. "Genetic diversity and main functional composition of Lingzhi strains from main producing areas in China." AMB Express vol. 11,1 (2021): 119. doi: https://doi.org/10.1186/s13568-021-01280-y
Liu YC, Tang XC, Hu HP, Chen DL, Xie YZ, Liang XW, Li XM, Xiao C, Huang LH, Wu QP. Genetic diversity and main functional composition of Lingzhi strains from main producing areas in China. AMB Express. 2021 Aug 21;11(1):119. doi: 10.1186/s13568-021-01280-y. PMID: 34417676; PMCID: PMC8379333.
Copy Download .nbib Format: NLM
Impact of simethicone on bowel cleansing during colonoscopy in Chinese patients.

World journal of clinical cases

Zhang H, Liu J, Ma SL, Huang ML, Fan Y, Song M, Yang J, Zhang XX, Song QL, Gong J, Huang PX, Zhang H.
PMID: 33869599
World J Clin Cases. 2021 Apr 06;9(10):2238-2246. doi: 10.12998/wjcc.v9.i10.2238.

BACKGROUND: Four-liter polyethylene glycol (PEG) solutions are effective for bowel cleansing, but their large volume might hinder patient compliance. Due to the unique features of Asians, 4 L PEG might be a suboptimal bowel preparation in predominantly ethnically Asian...

Cite
Zhang H, Liu J, Ma SL, et al. Impact of simethicone on bowel cleansing during colonoscopy in Chinese patients. World J Clin Cases. 2021;9(10):2238-2246doi: 10.12998/wjcc.v9.i10.2238.
Zhang, H., Liu, J., Ma, S. L., Huang, M. L., Fan, Y., Song, M., Yang, J., Zhang, X. X., Song, Q. L., Gong, J., Huang, P. X., & Zhang, H. (2021). Impact of simethicone on bowel cleansing during colonoscopy in Chinese patients. World journal of clinical cases, 9(10), 2238-2246. https://doi.org/10.12998/wjcc.v9.i10.2238
Zhang, Hu, et al. "Impact of simethicone on bowel cleansing during colonoscopy in Chinese patients." World journal of clinical cases vol. 9,10 (2021): 2238-2246. doi: https://doi.org/10.12998/wjcc.v9.i10.2238
Zhang H, Liu J, Ma SL, Huang ML, Fan Y, Song M, Yang J, Zhang XX, Song QL, Gong J, Huang PX, Zhang H. Impact of simethicone on bowel cleansing during colonoscopy in Chinese patients. World J Clin Cases. 2021 Apr 06;9(10):2238-2246. doi: 10.12998/wjcc.v9.i10.2238. PMID: 33869599; PMCID: PMC8026841.
Copy Download .nbib Format: NLM
Clinical characteristics and disease burden in prurigo nodularis.

Clinical and experimental dermatology

Aggarwal P, Choi J, Sutaria N, Roh YS, Wongvibulsin S, Williams KA, Huang AH, Boozalis E, Le T, Chavda R, Gabriel S, Kwatra SG.
PMID: 33969517
Clin Exp Dermatol. 2021 Oct;46(7):1277-1284. doi: 10.1111/ced.14722. Epub 2021 Jun 22.

BACKGROUND: Prurigo nodularis (PN) is a chronic inflammatory skin disease characterized by intense pruritus, but information on patient experience and impact on quality of life (QoL) remains understudied.AIM: To characterize disease characteristics and QoL in a global sample of...

Cite
Aggarwal P, Choi J, Sutaria N, et al. Clinical characteristics and disease burden in prurigo nodularis. Clin Exp Dermatol. 2021;46(7):1277-1284doi: 10.1111/ced.14722.
Aggarwal, P., Choi, J., Sutaria, N., Roh, Y. S., Wongvibulsin, S., Williams, K. A., Huang, A. H., Boozalis, E., Le, T., Chavda, R., Gabriel, S., & Kwatra, S. G. (2021). Clinical characteristics and disease burden in prurigo nodularis. Clinical and experimental dermatology, 46(7), 1277-1284. https://doi.org/10.1111/ced.14722
Aggarwal, P, et al. "Clinical characteristics and disease burden in prurigo nodularis." Clinical and experimental dermatology vol. 46,7 (2021): 1277-1284. doi: https://doi.org/10.1111/ced.14722
Aggarwal P, Choi J, Sutaria N, Roh YS, Wongvibulsin S, Williams KA, Huang AH, Boozalis E, Le T, Chavda R, Gabriel S, Kwatra SG. Clinical characteristics and disease burden in prurigo nodularis. Clin Exp Dermatol. 2021 Oct;46(7):1277-1284. doi: 10.1111/ced.14722. Epub 2021 Jun 22. PMID: 33969517.
Copy Download .nbib Format: NLM
Cost-effectiveness of Brentuximab Vedotin for relapsed or refractory systemic anaplastic large-cell lymphoma in China.

Journal of medical economics

Liu J, Zheng L, Chuang LH.
PMID: 34927526
J Med Econ. 2021 Dec 20;1-27. doi: 10.1080/13696998.2021.2020567. Epub 2021 Dec 20.

OBJECTIVES: Systemic anaplastic large-cell lymphoma (sALCL) is a rare hematological malignancy with poor prognosis, which is associated with significant economic burden. This study aimed to evaluate the cost-effectiveness of brentuximab vedotin (BV) in comparison to conventional chemotherapy in patients...

Cite
Liu J, Zheng L, Chuang LH. Cost-effectiveness of Brentuximab Vedotin for relapsed or refractory systemic anaplastic large-cell lymphoma in China. J Med Econ. 2021;1-27doi: 10.1080/13696998.2021.2020567.
Liu, J., Zheng, L., & Chuang, L. H. (2021). Cost-effectiveness of Brentuximab Vedotin for relapsed or refractory systemic anaplastic large-cell lymphoma in China. Journal of medical economics, 1-27. https://doi.org/10.1080/13696998.2021.2020567
Liu, Jia, et al. "Cost-effectiveness of Brentuximab Vedotin for relapsed or refractory systemic anaplastic large-cell lymphoma in China." Journal of medical economics vol. (2021): 1-27. doi: https://doi.org/10.1080/13696998.2021.2020567
Liu J, Zheng L, Chuang LH. Cost-effectiveness of Brentuximab Vedotin for relapsed or refractory systemic anaplastic large-cell lymphoma in China. J Med Econ. 2021 Dec 20;1-27. doi: 10.1080/13696998.2021.2020567. Epub 2021 Dec 20. PMID: 34927526.
Copy Download .nbib Format: NLM
Biochemical recurrence of pathological T2+ localized prostate cancer after robotic-assisted radical prostatectomy: A 10-year surveillance.

World journal of clinical cases

Yang CH, Lin YS, Ou YC, Weng WC, Huang LH, Lu CH, Hsu CY, Tung MC.
PMID: 33644166
World J Clin Cases. 2021 Feb 16;9(5):1026-1036. doi: 10.12998/wjcc.v9.i5.1026.

BACKGROUND: pT2+ prostate cancer (PCa), a term first used in 2004, refers to organ-confined PCa characterized by a positive surgical margin (PSM) without extracapsular extension. Patients with a PSM are vulnerable to biochemical recurrence (BCR) following radical prostatectomy (RP);...

Cite
Yang CH, Lin YS, Ou YC, et al. Biochemical recurrence of pathological T2+ localized prostate cancer after robotic-assisted radical prostatectomy: A 10-year surveillance. World J Clin Cases. 2021;9(5):1026-1036doi: 10.12998/wjcc.v9.i5.1026.
Yang, C. H., Lin, Y. S., Ou, Y. C., Weng, W. C., Huang, L. H., Lu, C. H., Hsu, C. Y., & Tung, M. C. (2021). Biochemical recurrence of pathological T2+ localized prostate cancer after robotic-assisted radical prostatectomy: A 10-year surveillance. World journal of clinical cases, 9(5), 1026-1036. https://doi.org/10.12998/wjcc.v9.i5.1026
Yang, Che Hseuh, et al. "Biochemical recurrence of pathological T2+ localized prostate cancer after robotic-assisted radical prostatectomy: A 10-year surveillance." World journal of clinical cases vol. 9,5 (2021): 1026-1036. doi: https://doi.org/10.12998/wjcc.v9.i5.1026
Yang CH, Lin YS, Ou YC, Weng WC, Huang LH, Lu CH, Hsu CY, Tung MC. Biochemical recurrence of pathological T2+ localized prostate cancer after robotic-assisted radical prostatectomy: A 10-year surveillance. World J Clin Cases. 2021 Feb 16;9(5):1026-1036. doi: 10.12998/wjcc.v9.i5.1026. PMID: 33644166; PMCID: PMC7896665.
Copy Download .nbib Format: NLM
[VOCs Emission Inventory and Variation Characteristics of Artificial Sources in Hubei Province in the Yangtze River Economic Belt].

Huan jing ke xue= Huanjing kexue

Dai LW, Meng J, Li QQ, Shi B, Su GJ, Huang LH.
PMID: 33742900
Huan Jing Ke Xue. 2021 Mar 08;42(3):1039-1052. doi: 10.13227/j.hjkx.202009043.

In this study, a 2018 anthropogenic volatile organic compounds (VOCs) emission inventory in Hubei Province was conducted using the emission factor method based on activity levels of five sources. The emission characteristics and variation trends of process sources from...

Cite
Dai LW, Meng J, Li QQ, et al. [VOCs Emission Inventory and Variation Characteristics of Artificial Sources in Hubei Province in the Yangtze River Economic Belt]. Huan Jing Ke Xue. 2021;42(3):1039-1052doi: 10.13227/j.hjkx.202009043.
Dai, L. W., Meng, J., Li, Q. Q., Shi, B., Su, G. J., & Huang, L. H. (2021). [VOCs Emission Inventory and Variation Characteristics of Artificial Sources in Hubei Province in the Yangtze River Economic Belt]. Huan jing ke xue= Huanjing kexue, 42(3), 1039-1052. https://doi.org/10.13227/j.hjkx.202009043
Dai, Ling-Wen, et al. "[VOCs Emission Inventory and Variation Characteristics of Artificial Sources in Hubei Province in the Yangtze River Economic Belt]." Huan jing ke xue= Huanjing kexue vol. 42,3 (2021): 1039-1052. doi: https://doi.org/10.13227/j.hjkx.202009043
Dai LW, Meng J, Li QQ, Shi B, Su GJ, Huang LH. [VOCs Emission Inventory and Variation Characteristics of Artificial Sources in Hubei Province in the Yangtze River Economic Belt]. Huan Jing Ke Xue. 2021 Mar 08;42(3):1039-1052. doi: 10.13227/j.hjkx.202009043. Chinese. PMID: 33742900.
Copy Download .nbib Format: NLM
Showing 565 to 576 of 576 entries